Montreal, April 17, 2023 – CanVECTOR's Clinical Trials & Shared Platforms platform recently concluded the 2022 Pilot Study Funding Competition. Following an independent evaluation by scientific and patient partner reviewers, we are pleased to announce that we've awarded $100,000 to principal investigator Federico Germini, MD - McMaster University and the team for the study titled Rivaroxaban Versus Low Molecular Weight Heparin (LMWH) for Extended Venous Thromboembolism (VTE) Prophylaxis After Hip Fracture Surgery: a Pilot Randomized Trial.

MONTREAL, February 27, 2023 – CanVECTOR's Training, Mentoring, and Early Career Development platform held its Fall 2022 Research Training (Fellowship) Awards competition, and following an independent review process, the platform is pleased to announce that Dr. Amye Harrigan, Dalhousie University, has been awarded a CanVECTOR Fellowship Award.

Hilton Toronto Downtown, Toronto, ON
June 8-9, 2016